Feed additive composition
Abstract
A feed additive composition comprising a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase, and a method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for avoiding the negative effects of necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject, which method comprising administering to a subject a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase.
Claims
exact text as granted — not AI-modified1 . A feed additive composition comprising a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase.
2 . A feed additive composition according to claim 1 wherein the direct fed microbial is an antipathogen direct fed microbial.
3 . A feed additive composition according to claim 1 or claim 2 wherein the direct fed microbial is a viable bacterium.
4 . A feed additive composition according to any one of claims 1 to 3 wherein the direct fed microbial comprises a bacterium from one or more of the following genera: Lactobacillus, Lactococcus, Streptococcus, Bacillus, Pediococcus, Enterococcus, Leuconostoc, Carnobacterium, Propionibacterium, Bifidobacterium, Clostridium and Megasphaera and combinations thereof.
5 . A feed additive composition according to any one of the preceding claims wherein the direct fed microbial comprises a bacterium from one or more of the following species: Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Enterococcus, Enterococcus spp, and Pediococcus spp, Lactobacillus spp, Bifidobacterium spp, Lactobacillus acidophilus, Pediococsus acidilactici, Lactococcus lactis, Bifidobacterium bifidum, Propionibacterium thoenii, Lactobacillus farciminus, lactobacillus rhamnosus, Clostridium butyricum, Bifidobacterium animalis ssp. animalis, Lactobacillus reuteri, Bacillus cereus, Lactobacillus salivarius ssp. salivarius, Megasphaera elsdenii, Propionibacteria sp and combinations thereof.
6 . A feed additive composition according to any one of the preceding claims wherein the direct fed microbial is one or more of the following strains: Bacillus subtilis strains 3A-P4 (PTA-6506); 15A-P4 (PTA-6507); 22C-P1 (PTA-6508); 2084 (NRRL B-500130); LSSA01 (NRRL-B-50104); BS27 (NRRL B-50105); BS 18 (NRRL B-50633); and BS 278 (NRRL B-50634).
7 . A feed additive composition according to any one of the preceding claims wherein the direct fed microbial is in the form of an endospore.
8 . A feed additive composition according any one of the preceding claims wherein the xylanase is an endo-1,4-β-d-xylanase or a 1,4 β-xylosidase preferably an endo-1,4-β-d-xylanase.
9 . A feed additive composition according to any one of the preceding claims wherein the xylanase is from Bacillus, Trichoderma, Thermomyces, Aspergillus, Penicillium and Humicola.
10 . A feed additive composition according to any one of the preceding claims wherein the protease is a subtilisin, a bacillolysin, an alkaline serine protease, a keratinase or a Nocardiopsis protease.
11 . A feed additive composition according to any one of the preceding claims wherein the phytase is a 6-phytase or a 3-phytase.
12 . A feed additive composition according to claim 11 wherein the phytase is a 6-phytase.
13 . A feed additive composition according to any one of the preceding claims wherein the phytase is an E. coli phytase or a Buttiauxella phytase or Hafnia phytase or a Citrobacter phytase or a Aspergillus phytase or a Penicillium phytase or a Trichoderma phytase or a Hansenula phytase.
14 . A feed additive composition according to any one of the preceding claims wherein the amylase is selected from one or more of the group consisting of: an α-amylase, a G4-forming amylase, a β-amylase and a γ-amylases.
15 . A feed additive composition according to claim 14 wherein the amylase is an α-amylase.
16 . A feed additive composition according to any one of the preceding claims wherein the amylase is from Bacillus licheniformis, B. amyloliquefaciens, Trichoderma spp. or Aspergillus spp.
17 . A feed additive composition according to any one of the preceding claims wherein the phytase is present at a dosage of between 200 FTU/g feed additive composition and 10000 FTU/g feed additive composition.
18 . A feed additive composition according to any one of the preceding claims wherein the amylase is present at a dosage of between 50 AU/g feed additive composition and 20000 AU/g feed additive composition.
19 . A feed additive composition according to any one of the preceding claims wherein the xylanase is present at a dosage of between 500 XU/g feed additive composition and 40000 XU/g feed additive composition.
20 . A feed additive composition according to any one of the preceding claims wherein the protease is present at a dosage of 1000 PU/g feed additive composition and 60000 PU/g feed additive composition.
21 . A feed additive composition according to any one of the preceding claims wherein the DFM is present at a dosage of 3.75×10 7 CFU/g feed additive composition and 1×10 11 CFU/g feed additive composition.
22 . A method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for improving the subjects resistance to necrotic enteritis or for improving feed conversion ratio (FCR) or for improving body weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject, or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject or for reducing populations of pathogenic bacteria in the gastrointestinal tract of a subject, or for reducing nutrient excretion in manure, which method comprising administering to a subject a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase.
23 . A method according to claim 22 comprising administering the feed additive composition according to any one of claims 1 - 21 .
24 . A method according to claim 22 or 23 wherein the direct fed microbial is an antipathogen direct fed microbial.
25 . A method according to any one of claims 22 - 24 wherein the direct fed microbial is a viable bacteria.
26 . A method according to any one of claims 22 to 25 wherein the direct fed microbial comprises a bacterium from one or more of the following genera: Lactobacillus, Lactococcus, Streptococcus, Bacillus, Pediococcus, Enterococcus, Leuconostoc, Carnobacterium, Propionibacterium, Bifidobacterium, Clostridium and Megasphaera and combinations thereof.
27 . A method according to any one of claims 22 - 26 wherein the direct fed microbial comprises a bacterium from one or more of the following species: Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Enterococcus, Enterococcus spp, and Pediococcus spp, Lactobacillus spp, Bifidobacterium spp, Lactobacillus acidophilus, Pediococsus acidilactici, Lactococcus lactis, Bifidobacterium bifidum, Propionibacterium thoenii, Lactobacillus farciminus, lactobacillus rhamnosus, Clostridium butyricum, Bifidobacterium animalis ssp. animalis, Lactobacillus reuteri, Bacillus cereus, Lactobacillus salivarius ssp. salivarius, Megasphaera elsdenii, Propionibacteria sp and combinations thereof.
28 . A method according to any one of claims 22 - 27 wherein the direct fed microbial is one or more of the following strains: Bacillus subtilis strains 3A-P4 (PTA-6506); 15A-P4 (PTA-6507); 22C-P1 (PTA-6508); 2084 (NRRL B-500130); LSSA01 (NRRL-B-50104); BS27 (NRRL B-50105); BS 18 (NRRL B-50633); and BS 278 (NRRL B-50634).
29 . A method according to any one of claims 22 - 28 wherein the direct fed microbial is in the form of an endospore.
30 . A method according to any one of claims 22 - 29 wherein the xylanase is an endo-1,4-β-d-xylanase or a 1,4 β-xylosidase preferably an endo-1,4-β-d-xylanase.
31 . A method according to any one of claims 22 - 30 wherein the xylanase is from Bacillus, Trichoderma, Thermomyces, Aspergillus, Penicillium and Humicola.
32 . A method according to any one of claims 22 - 31 wherein the protease is a subtilisin, a bacillolysin, an alkaline serine protease or a keratinase or a Nocardiopsis protease.
33 . A method according to any one of claims 22 - 32 wherein the phytase is a 6-phytase or a 3-phytase.
34 . A method according to claim 33 wherein the phytase is a 6-phytase.
35 . A method according to any one of claims 22 - 34 wherein the phytase is an E. coli phytase or a Buttiauxella phytase or Hafnia phytase or Citrobacter phytase or a Aspergillus phytase or a Penicillium phytase or a Trichoderma phytase or a Hansenula phytase.
36 . A method according to any one of claims 22 - 35 wherein the amylase is selected from one or more of the group consisting of: an α-amylase, a G4-forming amylase, a β-amylase and a 7-amylases.
37 . A method according to any one of claims 22 - 36 wherein the amylase is an α-amylase.
38 . A method according to any one of claims 22 - 37 wherein the amylase is from Bacillus licheniformis, B. amyloliquefaciens, Trichoderma spp. or Aspergillus spp.
39 . Use of a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility) or for improving nitrogen retention) or for improving the subject's resistance to of necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject or for reducing populations of pathogenic bacteria in the gastrointestinal tract of a subject, or for reducing nutrient excretion in manure.
40 . Use according to claim 39 wherein the feed additive composition according to any one of claims 1 - 21 is used.
41 . Use according to any one of claims 39 - 40 wherein the direct fed microbial is an antipathogen direct fed microbial.
42 . Use according to any one of claims 39 - 41 wherein the direct fed microbial is a viable bacterium.
43 . Use according to any one of claims 39 - 42 wherein the direct fed microbial comprises a bacterium from one or more of the following genera: Lactobacillus, Lactococcus, Streptococcus, Bacillus, Pediococcus, Enterococcus, Leuconostoc, Carnobacterium, Propionibacterium, Bifidobacterium, Clostridium and Megasphaera and combinations thereof.
44 . Use according to any one of claims 39 - 43 wherein the direct fed microbial comprises a bacterium from one or more of the following species: Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Enterococcus, Enterococcus spp, and Pediococcus spp, Lactobacillus spp, Bifidobacterium spp, Lactobacillus acidophilus, Pediococsus acidilactici, Lactococcus lactis, Bifidobacterium bifidum, Propionibacterium thoenii, Lactobacillus farciminus, lactobacillus rhamnosus, Clostridium butyricum, Bifidobacterium animalis ssp. animalis, Lactobacillus reuteri, Bacillus cereus, Lactobacillus salivarius ssp. salivarius, Megasphaera elsdenii, Propionibacteria sp and combinations thereof.
45 . Use according to any one of claims 39 - 44 wherein the direct fed microbial is one or more of the following strains: Bacillus subtilis strains 3A-P4 (PTA-6506); 15A-P4 (PTA-6507); 22C-P1 (PTA-6508); 2084 (NRRL B-500130); LSSA01 (NRRL-B-50104); BS27 (NRRL B-50105); BS 18 (NRRL B-50633); and BS 278 (NRRL B-50634).
46 . Use according to any one of claims 39 - 45 wherein the direct fed microbial is in the form of an endospore.
47 . Use according to any one of claims 39 - 46 wherein the xylanase is an endo-1,4-β-d-xylanase or a 1,4 β-xylosidase preferably an endo-1,4-β-d-xylanase.
48 . Use according to any one of claims 39 - 47 wherein the xylanase is from Bacillus, Trichoderma, Thermomyces, Aspergillus, Penicillium and Humicola.
49 . Use according to any one of claims 39 - 48 wherein the protease is a subtilisin, a bacillolysin, an alkaline serine protease or a keratinase or a Nocardiopsis protease.
50 . Use according to any one of claims 39 - 49 wherein the phytase is a 6-phytase or a 3-phytase.
51 . Use according to claim 50 wherein the phytase is a 6-phytase.
52 . Use according to any one of claims 39 - 51 wherein the phytase is an E. coli phytase or a Buttiauxella phytase or Hafnia phytase or Citrobacter phytase or a Aspergillus phytase or a Penicillium phytase or a Trichoderma phytase or a Hansenula phytase.
53 . Use according to any one of claims 39 - 52 wherein the amylase is selected from one or more of the group consisting of: an α-amylase, a G4-forming amylase, a β-amylase and a γ-amylases.
54 . Use according to any one of claims 39 - 53 wherein the amylase is an α-amylase.
55 . Use according to any one of claims 39 - 54 wherein the amylase is from Bacillus licheniformis, B. amyloliquefaciens, Trichoderma spp. or Aspergillus spp.
56 . A kit comprising a direct fed microbial, a protease, a xylanase, an amylase, a phytase and instructions for administration.
57 . A kit according to claim 56 wherein said kit comprises the feed additive composition according to any one of claims 1 - 21 .
58 . A kit according to any one of claims 56 - 57 wherein the direct fed microbial is an antipathogen direct fed microbial.
59 . A kit according to any one of claims 56 - 58 wherein the direct fed microbial is a viable bacterium.
60 . A kit according to any one of claims 56 - 59 wherein the direct fed microbial comprises a bacterium from one or more of the following genera: Lactobacillus, Lactococcus, Streptococcus, Bacillus, Pediococcus, Enterococcus, Leuconostoc, Carnobacterium, Propionibacterium, Bifidobacterium, Clostridium and Megasphaera and combinations thereof.
61 . A kit according to any one of claims 56 - 60 wherein the direct fed microbial comprises a bacterium from one or more of the following species: Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Enterococcus, Enterococcus spp, and Pediococcus spp, Lactobacillus spp, Bifidobacterium spp, Lactobacillus acidophilus, Pediococsus acidilactici, Lactococcus lactis, Bifidobacterium bifidum, Propionibacterium thoenii, Lactobacillus farciminus, lactobacillus rhamnosus, Clostridium butyricum, Bifidobacterium animalis ssp. animalis, Lactobacillus reuteri, Bacillus cereus, Lactobacillus salivarius ssp. salivarius, Megasphaera elsdenii, Propionibacteria sp and combinations thereof.
62 . A kit according to any one of claims 56 - 61 wherein the direct fed microbial is one or more of the following strains: Bacillus subtilis strains 3A-P4 (PTA-6506); 15A-P4 (PTA-6507); 22C-P1 (PTA-6508); 2084 (NRRL B-500130); LSSA01 (NRRL-B-50104); BS27 (NRRL B-50105); BS 18 (NRRL B-50633); and BS 278 (NRRL B-50634).
63 . A kit according to any one of claims 56 - 62 wherein the direct fed microbial is in the form of an endospore.
64 . A kit according to any one of claims 56 - 63 wherein the xylanase is an endo-1,4-β-d-xylanase or a 1,4 β-xylosidase preferably an endo-1,4-β-d-xylanase.
65 . A kit according to any one of claims 56 - 64 wherein the xylanase is from Bacillus, Trichoderma, Thermomyces, Aspergillus, Penicillium and Humicola.
66 . A kit according to any one of claims 56 - 65 wherein the protease is a subtilisin, a bacillolysin, an alkaline serine protease or a keratinase or a Nocardiopsis protease.
67 . A kit according to any one of claims 56 - 66 wherein the phytase is a 6-phytase or a 3-phytase.
68 . A kit according to claim 67 wherein the phytase is a 6-phytase.
69 . A kit according to any one of claims 56 - 68 wherein the phytase is an E. coli phytase or a Buttiauxella phytase or Hafnia phytase or Citrobacter phytase or an Aspergillus phytase or a Penicillium phytase or a Trichoderma phytase or a Hansenula phytase.
70 . A kit according to any one of claims 56 - 69 wherein the amylase is selected from one or more of the group consisting of: an α-amylase, a G4-forming amylase, a β-amylase and a γ-amylases.
71 . A kit according to any one of claims 56 - 70 wherein the amylase is an α-amylase.
72 . A kit according to any one of claims 56 - 71 wherein the amylase is from Bacillus licheniformis or, B. amyloliquefaciens, Trichoderma spp. or Aspergillus spp.
73 . A method of preparing a feed additive composition, comprising admixing a direct fed microbial with a protease, a xylanase, an amylase and a phytase and (optionally) packaging.
74 . A feed comprising a feed additive composition according to any one of claims 1 - 21 .
75 . A feed according to claim 74 wherein the phytase is present at a dosage of between 400 FTU/kg feed and 1000 FTU/kg feed.
76 . A feed according to claim 74 or claim 75 , wherein the amylase is present at a dosage of between 100 AU/kg feed and 2000 AU/kg feed.
77 . A feed according to any one of claims 74 - 76 wherein the xylanase is present at a dosage of between 1000 XU/kg feed and 4000 XU/kg feed.
78 . A feed according to any one of claims 74 - 77 wherein the protease is present at a dosage of between 2000 PU/kg feed to 6000 PU/kg feed.
79 . A feed according to any one of claims 74 - 77 wherein the DFM is present at a dosage of 7.5×10 4 CFU/kg feed and 1×10 7 CFU/kg feed.
80 . A method of preparing a feedstuff comprising admixing a feed component with a feed additive composition according to any one of claims 1 - 21 .
81 . A premix comprising a feed additive composition comprising a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase, and at least one mineral and/or at least one vitamin.
82 . A premix comprising a feed additive composition according to any one of claims 1 - 21 in combination with at least one mineral and/or at least one vitamin.
83 . A feed additive composition according to any one of claims 1 - 21 for preventing and/or treating coccidiosis and/or necrotic enteritis in a subject.
84 . A method of preventing and/or treating necrotic enteritis and/or coccidiosis wherein an effective amount of a feed additive composition according to any one of claims 1 - 21 is administered to a subject.
85 . A feed additive composition or feed or kit or method or use or premix as defined generally herein with reference to the Figures and the Examples.Join the waitlist — get patent alerts
Track US2014234279A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.